logo

For the Inventor, By the Inventor

Brookline, MA, United States of America

Sandor Szabo

This inventor holds 9 USPTO granted patents. Top assignees: The Brigham and Women's Hospital, Inc., Angio-Medical Corp., Boston University. Active years: 1982-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandor Szabo. Retrieved from https://idiyas.com/inventor/sandor-szabo-mp8kfw2r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 121(Granted Patents)


Company Filing History:

goldMedal8 out of 1,430 
 
The Brigham and Women's Hospital, Inc.
 patents
silverMedal1 out of 14 
 
Angio-Medical Corp.
 patents
bronzeMedal1 out of 833 
 
Boston University
 patents
4. 1 out of 72 
 
Creative Biomolecules, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1982-1993

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5239094 - Tetrahydro-S-21-Br (1993-08-24),
2. 5234908 - Method of treating gastrointestinal ulcers with platelet derived growth (1993-08-10),
3. 5223521 - Pyrazole and thiozole derivatives for treatment of gastrointestinal (1993-06-29),
4. 5214066 - Method for producing an animal model for inflammatory bowel disease (1993-05-25),
5. 5066496 - Composition and method for treatment of gastric and duodenal ulcers and (1991-11-19),
6. 4891356 - Proteinase inhibitors for treatment of gastrointestinal ulcer disease (1990-01-02),
7. 4612302 - Clinical use of somatostatin analogues (1986-09-16),
8. 4569926 - Stimulation of phagocytosis with somatostatin (1986-02-11),
9. 4366148 - Use of somatostatin in the prevention and cure of vascular, membrane, or (1982-12-28),

Title: Sandor Szabo: Innovator in Angiotropic Steroids

Introduction

Sandor Szabo is a notable inventor based in Brookline, MA, who has made significant contributions to the field of pharmaceuticals. He holds a total of nine patents, showcasing his innovative approach to medical treatments.

Latest Patents

Among his latest patents is Tetrahydro-S-21-Br, which is directed to novel angiotropic (angiogenic and angiostatic) steroids that are halogenated in the 21 position. This invention also includes novel methods for treating gastrointestinal ulcers through the administration of these angiotropic steroids. Another significant patent involves a method for treating ulcers of the gastrointestinal tract in mammals, which includes administering a therapeutically effective amount of Platelet-Derived Growth Factor (PDGF) to the gastrointestinal tract.

Career Highlights

Throughout his career, Sandor Szabo has worked with esteemed organizations such as Brigham and Women's Hospital and Creative Biomolecules. His work has focused on advancing medical treatments and improving patient outcomes through innovative solutions.

Collaborations

Sandor has collaborated with notable individuals in his field, including Klaus H. Usadel and Klaus W. Usadel, contributing to the advancement of research and development in pharmaceuticals.

Conclusion

Sandor Szabo's contributions to the field of angiotropic steroids and gastrointestinal treatments highlight his role as a significant innovator in the medical industry. His patents reflect a commitment to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…